Event Partner Content Agentic AI is Ready. Most Pharma Organizations Are Not Axtria Ignite 2026 returns June 10–11 in Princeton, New Jersey
Digital Sponsored Axtria Ignite 2025: A VIP roundtable on agentic AI At Axtria Ignite 2025, over 20 pharma senior executives stepped into a VIP roundtable to discuss how best to unlock agentic AI’s tranformative value.
Digital Agentic AI, culture shifts, and commercialisation today: Ant... Hear Anthony Cilento, VP, data science & customer insights, at Bayer, in a post-Axtria Ignite 2025 discussion on the conference and agentic AI.
Digital Axtria Ignite 2025: Ritesh Mehra talks AI, culture, and comm... At Axtria Ignite 2025, web editor Nicole Raleigh spoke with Ritesh Mehra, CFO, US, at Ferring Pharmaceuticals.
Digital Sponsored Axtria Ignite 2025: Building on GenAI’s foundation with agen... Hundreds of senior executives representing major pharma companies met last month at Axtria Ignite 2025 to discuss the future of agentic AI in the industry.
News Novartis snaps up PI3Kα breast cancer drug in $3bn deal Novartis has agreed to buy a PI3Kα-targeting drug for breast cancer from Synnovation, a potential successor to its Piqray brand, for $2bn upfront.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
